Glenn Block
Corporate Officer/Principal at Merz Pharmaceuticals LLC
Profile
Glenn Block is currently the Vice President & Head-US Neurosciences at Merz Pharmaceuticals LLC since 2013.
Prior to this, he was the President & General Manager at Merz Pharma Canada Ltd.
Mr. Block completed his undergraduate degree at Queen's University.
Glenn Block active positions
| Companies | Position | Start |
|---|---|---|
Merz Pharmaceuticals LLC
 Merz Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Merz Pharmaceuticals LLC manufactures dermatology and podiatry products for skin foot and nail care. Its products include Mederma, which is used to treat scarring, Appearex and Erygel, which treats weak and brittle nails. The company is headquartered in Greensboro, NC. | Corporate Officer/Principal | 09/10/2013 |
Former positions of Glenn Block
| Companies | Position | End |
|---|---|---|
Merz Pharma Canada Ltd.
 Merz Pharma Canada Ltd. Pharmaceuticals: MajorHealth Technology Merz Pharma Canada Ltd. engages in the research and market of drugs for treatment of neurological and psychiatric diseases. Its products include Belotero, Radiesse, Ultherapy, Xeomin, Neocutis, and Mederma. The company was founded in 2009 and is headquartered in Burlington, Canada. | President | - |
Training of Glenn Block
| Queen's University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Merz Pharmaceuticals LLC
Merz Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Merz Pharmaceuticals LLC manufactures dermatology and podiatry products for skin foot and nail care. Its products include Mederma, which is used to treat scarring, Appearex and Erygel, which treats weak and brittle nails. The company is headquartered in Greensboro, NC. | Health Technology |
Merz Pharma Canada Ltd.
Merz Pharma Canada Ltd. Pharmaceuticals: MajorHealth Technology Merz Pharma Canada Ltd. engages in the research and market of drugs for treatment of neurological and psychiatric diseases. Its products include Belotero, Radiesse, Ultherapy, Xeomin, Neocutis, and Mederma. The company was founded in 2009 and is headquartered in Burlington, Canada. | Health Technology |
- Stock Market
- Insiders
- Glenn Block